Your browser doesn't support javascript.
loading
Qiangjing tablets ameliorate asthenozoospermia via mitochondrial ubiquitination and mitophagy mediated by LKB1/AMPK/ULK1 signaling.
Li, Guangsen; Xu, Yuanjie; Li, Yingxi; Chang, Degui; Zhang, Peihai; Ma, Ziyang; Chen, Di'ang; You, Yaodong; Huang, Xiaopeng; Cai, Jian.
Afiliação
  • Li G; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Xu Y; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Li Y; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Chang D; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Zhang P; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Ma Z; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Chen D; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • You Y; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Huang X; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Cai J; Department of Urology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Pharm Biol ; 61(1): 271-280, 2023 Dec.
Article em En | MEDLINE | ID: mdl-36655371

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Astenozoospermia Limite: Animals Idioma: En Revista: Pharm Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Astenozoospermia Limite: Animals Idioma: En Revista: Pharm Biol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido